“FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Efficacy and Safety From a Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study”, J of Skin, vol. 2, p. S56, Dec. 2018, doi: 10.25251/skin.2.supp.56.